Skip to main content

Table 1 Collaborative Group with Site-specific Primary Outcome and Sample Size

From: The methodology for developing a prospective meta-analysis in the family planning community

Institution

Primary investigator

Route & timing* of misoprostol administration

Site-specific primary outcome

Target recruitment

Emory University School of Medicine

Eva Lathrop

buccal 2 hours prior

Ability to have the IUD inserted without the use of ancillary measures including mechanical dilation of the cervix, placement of paracervical nerve block, or using abdominal ultrasound for guidance.

75

Oregon Health & Science University

Alison Edelman

Buccal, 90 minutes

Patient perceived pain on 100-mm visual analogue scale (VAS;anchors:0 = none,100 mm = worst imaginable)

40

University of Arizona

Pamela Lotke

Vaginal or buccal 2 hours prior

Patient perceived pain on 100-mm visual analogue scale (VAS;anchors:0 = none,100 mm = worst imaginable)

60

University of Colorado

Stephanie Teal

Sublingual, 2 hours prior

Able to have the IUD inserted in a standard fashion without the ancillary measures of mechanical dilation of the cervix, placement of paracervical nerve block, or using abdominal ultrasound for guidance.

150

University of New Mexico

Eve Espey

Buccal, 2 hours prior

Patient perceived pain on 100-mm visual analogue scale (VAS;anchors:0 = none,100 mm = worst imaginable)

80

University of Utah

David Turok

Buccal or vaginal 2-4 hours prior

Operator perceived ease of insertion (based on a 100-mm visual analogue scale -anchors: 0 _ extremely easy, 100 mm_impossible).

100

  1. *"timing" reflects number of minutes misoprostol will be administered prior to IUD insertion